IGMS
Price
$1.32
Change
+$0.08 (+6.45%)
Updated
Jun 6 closing price
Capitalization
74.84M
65 days until earnings call
THRD
Price
$5.29
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
238.73M
61 days until earnings call
Interact to see
Advertisement

IGMS vs THRD

Header iconIGMS vs THRD Comparison
Open Charts IGMS vs THRDBanner chart's image
IGM Biosciences
Price$1.32
Change+$0.08 (+6.45%)
Volume$369.87K
Capitalization74.84M
Third Harmonic Bio
Price$5.29
Change-$0.00 (-0.00%)
Volume$199.43K
Capitalization238.73M
IGMS vs THRD Comparison Chart
Loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGMS vs. THRD commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMS is a StrongBuy and THRD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (IGMS: $1.32 vs. THRD: $5.29)
Brand notoriety: IGMS and THRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGMS: 210% vs. THRD: 30%
Market capitalization -- IGMS: $74.84M vs. THRD: $238.73M
IGMS [@Biotechnology] is valued at $74.84M. THRD’s [@Biotechnology] market capitalization is $238.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGMS’s FA Score shows that 0 FA rating(s) are green whileTHRD’s FA Score has 1 green FA rating(s).

  • IGMS’s FA Score: 0 green, 5 red.
  • THRD’s FA Score: 1 green, 4 red.
According to our system of comparison, THRD is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGMS’s TA Score shows that 5 TA indicator(s) are bullish while THRD’s TA Score has 3 bullish TA indicator(s).

  • IGMS’s TA Score: 5 bullish, 4 bearish.
  • THRD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IGMS is a better buy in the short-term than THRD.

Price Growth

IGMS (@Biotechnology) experienced а +3.94% price change this week, while THRD (@Biotechnology) price change was +1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

IGMS is expected to report earnings on Aug 11, 2025.

THRD is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
THRD($239M) has a higher market cap than IGMS($74.8M). THRD YTD gains are higher at: -48.591 vs. IGMS (-78.396). THRD has higher annual earnings (EBITDA): -66.25M vs. IGMS (-199.47M). THRD has more cash in the bank: 272M vs. IGMS (184M). THRD has less debt than IGMS: THRD (3M) vs IGMS (45.2M). IGMS has higher revenues than THRD: IGMS (2.68M) vs THRD (0).
IGMSTHRDIGMS / THRD
Capitalization74.8M239M31%
EBITDA-199.47M-66.25M301%
Gain YTD-78.396-48.591161%
P/E RatioN/AN/A-
Revenue2.68M0-
Total Cash184M272M68%
Total Debt45.2M3M1,506%
TECHNICAL ANALYSIS
Technical Analysis
IGMSTHRD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 17 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAVE221.5512.38
+5.92%
Dave
TFIN58.801.81
+3.18%
Triumph Financial
SHEL68.020.49
+0.73%
Shell plc
ROIV11.230.03
+0.27%
Roivant Sciences Ltd
SRZN8.50-0.14
-1.62%
Surrozen

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+6.45%
MRSN - IGMS
56%
Loosely correlated
+4.78%
DYN - IGMS
50%
Loosely correlated
+5.08%
CRNX - IGMS
48%
Loosely correlated
+2.13%
MDGL - IGMS
42%
Loosely correlated
+1.51%
ATXS - IGMS
41%
Loosely correlated
+14.75%
More

THRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with APGE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
N/A
APGE - THRD
42%
Loosely correlated
+8.84%
NVAX - THRD
42%
Loosely correlated
+6.58%
IGMS - THRD
41%
Loosely correlated
+6.45%
ACLX - THRD
35%
Loosely correlated
+2.79%
ADMA - THRD
35%
Loosely correlated
+3.36%
More